|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Immunohistochemistry was combined with retrograde tracing
techniques to characterize the effect of nerve growth factor (NGF) on substance P (SP) producing vagal neurons innervating the
guinea pig trachea. Fast blue dye instilled into the trachea retrogradely labeled nerve cell bodies located in the nodose and jugular ganglia. In untreated guinea pigs > 99% of the SP-containing
neurons labeled with fast blue were located in the jugular ganglia.
The SP-positive neurons were small in diameter (23 ± 1 µm) and
were negative for neurofilament immunoreactivity. The fast-blue-positive neurons in the nodose ganglia, by contrast, were large in
diameter (40 ± 3 µm) and were negative for SP immunoreactivity
and positive for neurofilament immunoreactivity. After NGF-
injections into the tracheal wall, approximately 10% of the large-diameter nodose neurofilament-positive neurons projecting fibers
to the trachea became SP-positive (p < 0.05). We previously demonstrated that nodose nerve endings supplying the trachea are
exquisitely mechanically sensitive, but capsaicin- and bradykinin-insensitive. These results suggest that NGF not only increases SP
expression in airway neurons, but changes the neuronal phenotype such that large, capsaicin-insensitive nodose neurons with
fast-conducting "A
" fibers provide a component of the tachykinergic innervation.
| |
INTRODUCTION |
|---|
|
|
|---|
Using retrograde tracing techniques, the predominant afferent supply to the guinea pig airway has been shown to be provided by the vagus nerve (1). The cell bodies of the vagal afferent fibers are located in either of two embryologically distinct ganglia, namely the jugular and nodose ganglia. Combining retrograde tracing with immunohistochemistry, approximately 30% of the afferent fibers innervating the guinea pig trachea have been found to contain tachykinins, substance P (SP), and neurokinin A (2). Virtually all of these neurons are small-diameter neurons located mostly in the jugular ganglia. Only about 1% of the cell bodies of airway afferent fibers located in the nodose ganglia contain SP. Another distinction between nodose and jugular neurons innervating the guinea pig trachea is that the nerve fibers located in the epithelium are almost exclusively derived from cell bodies situated in the jugular ganglia (3).
Physiological studies have revealed that nerve endings arising from the jugular ganglia are analogous to the so-called nociceptive fiber type, where they are only moderately sensitive to mechanical force, but respond vigorously to capsaicin, bradykinin, hydrogen ions, and changes in osmolarity (2, 4, 5). The airway nerve endings arising from the nodose ganglia, by contrast, do not respond to these inflammatory-associated stimuli, but rather are exquisitely sensitive to mechanical force (2). Considering the anatomical data with the physiological studies, it appears that SP-containing fibers in guinea pig airways are nociceptive-like C fibers that arise selectively from the jugular ganglia and project to the epithelial layer.
Many studies have demonstrated quantitative increases in
the tachykinin content of afferent nerves innervating visceral
tissues caused by inflammatory processes (6). This can also
be observed in the airways, where allergic inflammation leads
to substantial increases in the content of sensory neuropeptides (9). It has recently been reported in the somatosensory
system that inflammation not only causes quantitative changes
in sensory neuropeptides, it is also associated with a qualitative change in tachykinin neurobiology, such that SP production is induced in the fast conducting A
-fiber type (10).
Nerve growth factor (NGF) is known to be elevated in allergically inflamed airways (11, 12). Moreover, NGF is capable of
regulating the expression of tachykinin genes in adult sensory neurons (13). Therefore, in the present study, experiments were designed to address two hypotheses. First, that NGF in the airways could lead to increases in the expression
of tachykinins in airway-specific sensory neurons and second,
that NGF could lead to a qualitative change in the nature of
the sensory neurons expressing tachykinins.
The results support the hypothesis that NGF may serve as a signaling molecule in the transduction of inflammation by elevating sensory neuropeptide production in the airways. We also provide evidence that there is a phenotypic change in the nature of the tachykinergic neurons carried by the vagus nerve after NGF exposure, such that SP production is induced in large-diameter capsaicin-insensitive nodose neurons innervating the airways.
| |
METHODS |
|---|
|
|
|---|
Male guinea pigs (150 to 250 g; Harlan Sprague-Dawley, Inc., Indianapolis, IN) were used to study the effect of NGF on tachykinin expression of airway-specific sensory neurons. On Day 1, 30 µl of a retrograde tracer (fast blue) was instilled into the upper trachea of the
guinea pig. After 7 d, the trachea of control and experimental animals
were injected with 50 µl of vehicle (normal saline) or NGF-
(1 µg/µl),
respectively. After 24 h, control and NGF-treated guinea pigs were
killed (overdose of carbon dioxide) and the nodose and jugular ganglia
were removed and prepared for SP- and neurofilament (NF)-immunohistochemistry. Thus, the experimental design consisted of two groups:
a control group of four guinea pigs that received instillation of fast blue
and 50-µl injection of saline into the proximal trachea and an experimental group of four guinea pigs that received 30 µl instillation of fast-blue and 50-µl injection of NGF-
into the proximal trachea.
Tracheal Instillation of Retrograde Tracers and NGF Injection
Guinea pigs were anesthetized by an intramuscular injection of ketamine hydrochloride (50 mg/kg) and xylazine hydrochloride (2.5 mg/kg). A volume of 30 µl of 5% fast blue (Sigma Chemical Co., St.
Louis, MO) was instilled into the proximal region of the trachea using
a Hamilton microsyringe with a curved metal feeding tube connected
to the syringe. In addition, flexible wire covered with gauze was connected to a plexiglass board elevated 45°. The guinea pig was placed
on the board and the gauze wire was positioned behind the upper incisors to aid in the extension of the head and the opening of the mouth.
Gauze-covered forceps were used to deflect the tongue outward and
ventral. A light was positioned for optimal visualization of the posterior oral cavity. The feeding tube connected to the microsyringe was
deflected downward past the posterior region of the tongue and into
the laryngeal orifice. Once an increase in resistance was felt, the feeding tube was pushed through the laryngeal orifice and the tracer was immediately instilled into the proximal trachea. Upon entrance into
the trachea, the microsyringe was rotated in a circular pattern to enable a greater chance of tracer distribution around the circumference of the trachea. The animal was then removed from the plexiglass board and positioned supine during recovery from anesthesia. With this technique, we have previously noted that the fluorescent dye is
limited to the rostral region of the trachea (3). Seven days later the
animal was again anesthetized, and using sterile techniques, a small
incision was made in the rostral portion of the trachea. Using a Hamilton syringe, 50 µl of NGF-
(1 µg/ml), or the diluent (normal saline),
was injected circumferentially into the tracheal wall.
Tissue Removal and Preparation
One day after saline or NGF injection, the experimental and control animals were killed by 100% CO2 asphyxiation and exsanguinated. The right nodose ganglion and right jugular ganglion were removed. All tissues were fixed in picric acid-formaldehyde fixative for 3 h at 4° C. The fixative consisted of 2% paraformaldehyde, 15% saturated picric acid, and 0.15 M phosphate buffer. The tissues were rinsed 3 times with a 0.1 M phosphate-buffered saline (PBS) containing 0.3% Triton-X-100 (PBS-Tx). During the final rinse, the tissues remained in the PBS-Tx overnight at 4° C.
The nodose and jugular ganglia were mounted with a specific orientation on corks so that the first section collected was of the ventral
surface. The ganglia were frozen in isopentane, cooled with liquid nitrogen, and stored in airtight plastic bags at
60° C.
Continuous serial cryostat sections (12-µm thickness) of the nodose and jugular ganglia were collected sequentially on four different subbed coverslips. The first coverslip had sections 1, 5, 9, . . . , the second coverslip had sections 2, 6, 10, . . . and so on. The entire ganglia was sectioned, however not every section was evaluated. The retrograde labeling by fast blue was analyzed on all evaluated sections. Coverslips 1 and 2 were used for SP immunocytochemistry. Coverslips 3 and 4 were used for NF and SP colocalization immunohistochemistry studies and cell diameter determination of the colocalized neurons.
SP Immunocytochemical Procedures
Immunocytochemical procedures for localizing a single antigen are identical to those described previously (3). Briefly, cryostat sections on gelatin-coated coverslips were covered with a diluted primary antiserum, rabbit anti-SP (Peninsula Laboratories, Belmont, CA; 1:200 working dilution). The coverslips were incubated in a humidified chamber at 37° C for 30 min. The coverslips were rinsed with a 1% bovine serum albumin-phosphate saline buffer containing triton-X solution (PBS-Tx + BSA) three times, allowing 5 min for each rinse. The sections on the coverslips were covered with a diluted secondary antiserum, fluorescein isothiocyanate-labeled goat anti-rabbit (Peninsula Laboratories, 1:200 working dilution) and incubated at 37° C for 30 min. The coverslips were rinsed again in PBS-Tx + BSA, three times for 5 min. The coverslips containing alternate sections of nodose or jugular ganglia were mounted using fluoromount. Controls for specificity of primary antisera consisted of absorption of 1 µg/ml antisera with SP. Nonspecific background labeling was determined by omission of primary antiserum. Even after these controls were employed, however, cross-reactivity of antisera with other known or unknown peptides present in the tissue cannot be excluded by immunocytochemical procedures. Therefore, the term peptide-immunoreactivity (i.e., SP-IR) is used here when referring to labeled structures.
Without further processing, the sections were analyzed for the distribution of fast blue-labeled vagal ganglia neurons containing SP-IR. Twenty-four sections were observed and used to count the total number of fast blue-labeled nerve cell bodies containing SP-IR and the overall number of nerve cell bodies in each vagal ganglia labeled with fast-blue. The sections were counted by direct observation using a laboratory cell counter and only counted neurons with a defined nucleus. The percentage of fast blue-labeled neurons containing SP-IR was calculated for each vagal ganglion by dividing the number of fast blue- labeled cell bodies containing SP-IR by the total number of fast blue- labeled cell bodies.
SP and NF Colocalization Immunocytochemical Procedures
Previous studies showed that all NF-positive neurons were SP-negative and essentially all NF-negative neurons were SP-positive (2).
Therefore, we used NF-IR as a marker for large, myelinated A
fibers
and SP-IR as an indicator for small, unmyelinated fibers by colocalizing these two antigens (2). The immunofluorescence for SP was described previously. The primary antisera used for NF-IR (160 kD) was
a mouse monoclonal anti-NF (Boehringer Mannheim, Indianapolis,
IN; Clone NN18, diluted 1:30). The mouse antibody was labeled by a
biotinylated goat-anti-mouse IgG (Amersham Life Science, Piscataway, NJ; diluted 1:50) followed by a streptavidin-Texas Red conjugate (Molecular Probes, Eugene, OR; diluted 1:100).
These sections were analyzed for the distribution of fast blue- labeled vagal (nodose or jugular) ganglia neurons containing colocalized SP- and NF-immunoreactivity. A sample population of 200 fast blue-labeled neurons representing four ganglia (nodose or jugular) from saline- and NGF-treated animals were randomly selected for observation. The percentage of fast blue-labeled vagal neurons containing colocalized SP-IR and NF-IR were calculated by dividing the number of fast blue-labeled cell bodies, nodose or jugular, containing SP-IR and NF-IR by the total number of fast blue-labeled cell bodies, nodose or jugular. The same criterion was followed to identify and count neurons as described previously.
In addition to identifying the colocalized vagal labeled neurons, the neuronal diameter was also measured from this population of vagal neurons. The long axis of the nucleated cell body and the short axis perpendicular to it were measured by using a calibrated ocular grid. The mean of the long and short axis was taken as the "neuronal diameter" throughout processing the data.
Determination of Sensory Fiber Conduction Velocities
The conduction velocities of nodose and jugular nerve fibers with mechanosensitive receptive fields in the trachea were determined as previously described (2). Briefly, the trachea was isolated with the right vagus nerves and associated sensory ganglia intact from saline-treated guinea pigs. The trachea and vagal ganglia were separately superfused with Krebs bicarbonate buffer solution (maintained at 37° C) and gassed with a combination of 95% oxygen and 5% carbon dioxide. Single fiber activity was discriminated by placing a concentric electrical stimulating electrode on the recurrent laryngeal nerve, through which the majority of fibers enter the trachea. The recording electrode was placed within the ganglion and manipulated until a single unit activity was detected. When electrically evoked action potentials were seen, the stimulator was switched off and the trachea and bronchi were gently brushed with a von Frey filament. Mechanically sensitive receptive fields were revealed when a burst of action potentials was elicited in response to von Frey filament stimulation. Conduction velocities were calculated by electrically stimulating the receptive field with a single 0.1-ms square pulse of suprathreshold current using a concentric ring electrode, and then measuring the distance traveled along the nerve pathway divided by the time between the shock artifact and the recorded action potential.
Data Analysis
The counting of all neurons was carried out by two investigators in an unbiased manner. The counting was carried out in a "blind" fashion, i.e., the investigator counting the neurons did not know the treatment status of the ganglion studied. The differences among the treatment groups in the percentage of cells that contained SP-immunoreactivity were analyzed for statistically significant differences using a chi-squared analysis (Statview II program; Abacus Concepts, Lafayette, CA).
Photomicrographic Illustrations
After the coverslips of the nodose and jugular ganglia were mounted with fluoromount, the sections were observed using an Olympus DX60 fluorescence microscope equipped with fluorescein (excitation 455 to 500 and emission 515 to 535 nm), rhodamine (excitation 520 to 550 nm and emission 590 to 620 nm), and ultraviolet (excitation 330 to 385 nm and emission 420 to 460 nm) filters. The sections were photographed with an Olympus PM-C35PX camera. The slides were scanned into Adobe PhotoDeluxe 1.0 program for the Power Macintosh using the Polaroid SprintScan 35 system. Digital images were printed on an Epson 700 Stylus Printer without additional image processing.
| |
RESULTS |
|---|
|
|
|---|
Nodose Ganglion Neurons Innervating the Trachea
In nodose ganglia obtained from control (normal saline-treated)
guinea pigs, 838 neurons were retrogradely labeled from the trachea. Among these fast blue-labeled neurons only 2.9 ± 0.53% (24 of 838) were SP-IR. Although less than 3%, this
value is larger than the 1.0 ± 0.05% (4/399) and 1% (3/267) we
obtained in two of our previous studies (2, 3). This may be due
to the fact that in the present study the animals were subjected
to a minor surgical procedure for normal saline injection. In
nodose ganglia obtained from guinea pigs in which the trachea
was treated with NGF-
(1 µg/µl), a significant 3.6-fold increase was noted in the percentage of neurons that were SP-IR, such that now 10 ± 1.07% (52 of 492) of the fast blue-
labeled neurons were SP-positive (Figure 1).
|
We have previously reported that tracheal-specific neurons in the nodose ganglia that were SP-negative, were nearly uniformly large in diameter, and stained positively with antibodies against NF-160 kDa protein (2). We therefore addressed the hypothesis that NGF caused a phenotypic switch in the tachykinergic innervation such that large neurons that are NF-IR also become SP-positive (Table 1). We randomly sampled sections from four ganglia obtained from saline-treated animals, analyzing the first 100 nodose neurons that were retrogradely labeled from the trachea. As expected, of these 100 neurons, 98 were NF-IR and had relatively large (> 30 µm) somal diameters. Consistent with our previous findings, none of the 98 NF-positive neurons were SP-positive (Figure 3). Two of 100 nodose neurons that stained positively for SP were NF-IR negative, and had small somal diameters (18 and 20 µm), indicative of C-fiber neurons. In nodose ganglia obtained from animals that received tracheal injection of NGF, 96 of 100 retrogradely labeled nodose neurons had large somal diameters and were NF-IR. Among this large-diameter NF-positive population, eight were also clearly positive for SP-immunoreactivity (Figure 4). This is consistent with the induction of SP production in approximately 10% of the large-diameter airway-specific nodose neuron population.
|
|
|
Conduction velocity. We measured the conduction velocity
of 264 nodose fibers with mechanically sensitive nerve endings
in the trachea. Only 10 fibers had conduction velocities in the
C-fiber range of
1 m/s. The conduction velocity of these
10 fibers averaged 0.7 ± 0.1 m/s. The remaining 254 fibers
had conduction velocities in the A
range that averaged 5.0 ± 0.2 m/s.
Jugular Ganglia Neurons Innervating the Trachea
We investigated a total of 867 airway-specific (retrogradely labeled) neurons in the jugular ganglia. Consistent with our previous reports (1, 2), approximately 40 ± 1.0% of the jugular neurons projecting fibers to the trachea were SP-positive. This increased slightly to 56 ± 3.1% in NGF-treated animals (Figure 2). To address the hypothesis that NGF induced a phenotypic switch in the type of SP-positive neurons of the jugular ganglion, we evaluated the cell diameter and NF-immunoreactivity.
|
In saline-treated animals 47 of 100 jugular neurons retrogradely labeled from the airway had relatively large somal diameters (> 30 µm), and were NF-IR (Table 1). None of these 47 NF-positive neurons were positive for SP-immunoreactivity. Among the 53 NF-negative neurons, by contrast, all were SP-positive, and had relatively small diameters, averaging 20 ± 2 µm. In jugular ganglia obtained from animals in which the trachea was previously injected with NGF, 39 of 100 neurons had large somal diameters and were NF-positive. Among these neurons, 13 were also SP-positive. This NGF-induced population of SP-positive neurons had cell diameters that were significantly larger than the diameters of the SP-positive population of neurons in the saline-treated animals (33 ± 2 µm versus 20 ± 2 µm, Table 1).
Conduction velocity. The conduction velocities of 231 jugular fibers with mechanically sensitive receptive fields in the
trachea/bronchus were investigated. Among this population,
124 fibers (53%) conducted action potentials < 1 m/s with an
average velocity of 0.8 ± 0.02 m/s. The remaining fibers conducted action potentials in the A
range (5.6 ± 0.3 m/s).
| |
DISCUSSION |
|---|
|
|
|---|
In this study we have demonstrated that NGF, a molecule elevated during airway inflammation (11, 12), not only increases the percentage of airway-specific sensory neurons that express SP-IR, but also leads to a phenotypic switch in the nature of vagal sensory neurons producing this sensory neuropeptide.
Retrograde labeling studies have demonstrated that the vast majority of sensory nerves innervating the trachea and central airways in mammals travel in the vagus nerves. In guinea pigs, approximately half of these fibers emanate from cell bodies located in the nodose ganglia and the other half from cell bodies located in the jugular ganglia (1). Studies on the development of the sensory nervous system have revealed that the nodose and jugular ganglia are distinct structures from an embryological viewpoint, with the former having a placodal origin and the latter arising from the neural crest (14, 15). A growing body of evidence is accumulating to reveal that nerve fibers from these ganglia are also anatomically and physiologically distinct. Consistent with previous studies in the guinea pig (1) and rat (16), we found that SP neurons innervating the guinea pig airways were derived nearly exclusively from the jugular ganglia. In normal saline-treated animals, approximately 50% of the jugular neurons projecting to the trachea were SP-IR. This correlates well with our observation that about 50% of the jugular fibers projecting to the trachea conducted action potentials in the C fiber range. Also supporting the contention that SP-IR neurons project C-fibers to the airways was the observation that SP-IR was found in small neurons with diameters of only about 20 µm that were not immunoreactive to NF. We have previously reported that the jugular C fibers projecting to the airways are only modestly sensitive to mechanical stimulus, but are strongly activated by stimulus such as bradykinin, capsaicin, decreases in pH, and increases in osmolarity (2, 4, 17). These data support the hypothesis that under normal conditions the tachykinergic innervation of guinea pig trachea is derived from jugular C fibers that are analogous to the so-called nociceptive fibers in the somato sensory system.
In the NGF-treated airways, SP production was induced in
a population of airway-specific nodose ganglion neurons.
These SP-IR nodose neurons had somal diameters that were
significantly larger than the SP-IR neurons observed in saline-treated animals. These SP-positive nodose neurons have relatively large somal diameters, which is also consistent with the
hypothesis that their fibers conduct action potentials at velocities in the A
range. Supporting this contention is our finding
regarding the conduction velocity of the 264 nodose nerve fibers studied with receptive fields in the trachea; 97% of them
conducted action potentials in the A
range. Elegant studies
in the dorsal root ganglia have correlated immunoreactivity to
NF protein with somal diameter and conduction velocity (18,
19). Thus, neurons projecting C fibers were typically poorly
stained with antibodies to NF, whereas large neurons with fast
conducting fibers stained intensely for NF protein. We have
made similar correlations in the guinea pig vagal sensory ganglia (2). Therefore, also supporting our hypothesis that NGF
induces SP production in fast conducting neurons is the observation that the percentage of NF-positive neurons that produce SP increase after NGF exposure from 0% to nearly 10%.
It should be noted that fast-blue dye was instilled into the tracheal lumen, whereas NGF was injected into a very localized
region of the trachea wall and thus a portion of the fast blue-
labeled nerve population may not have been exposed to effective concentrations of NGF. If this is true, 10% may underestimate the efficacy of NGF at inducing SP production in nodose
neurons. In any event, the present results lead logically to the
hypothesis that after NGF exposure, there is a phenotypic
change in airway-specific neurons such that large-diameter
neurons that project fast conducting A
fibers begin to produce SP. Thus, showing that nodose ganglia neurons contribute to the tachykinergic innervation of inflamed airways is
consistent with the recent findings of Fischer and coworkers who demonstrated that within 1 d after allergen exposure preprotachykinin gene expression and SP production are elevated
in nodose ganglia neurons (9).
Exposing the trachea to NGF also caused a qualitative
change in the nature of jugular neurons expressing SP. Consistent with our previous studies (2), the conduction velocity
analysis of guinea pig airway sensory nerves arising from the
jugular ganglia was divided equally in number between C fibers and A
fibers. In saline-treated animals the airway-
labeled SP-positive neurons were uniformly found in small-
diameter cells that were not NF-IR. This is consistent with the
conclusion that these neurons belong to the capsaicin-sensitive
C-fiber class (2). As with the nodose ganglia, after NGF treatment there was a phenotypic switch in the airway-specific tachykinergic population of neurons in the jugular ganglia such that
approximately 30% of the large-diameter, NF-positive (presumably A
-fiber) neurons projecting fibers to the trachea began to express SP-immunoreactivity.
There are substantive implications to a qualitative change
in the tachykinergic innervation of the airways from jugular C fibers to nodose and jugular A fibers. Unlike the jugular C-fiber nerve endings, nodose nerve endings in the guinea pig airway
are very sensitive to mechanical stimulation (2). The neurons
induced by NGF to produce SP may therefore be stimulated
by mechanical forces that are not nociceptive, but may occur
even during normal breathing. There is indirect evidence that
the nodose fibers innervate the region of the airway beneath
the basement membrane, whereas jugular nerve fibers extend
into the epithelium (3). If the SP were to be released from the
induced nodose fiber population, it would likely affect different cell populations than those released from the constitutive
jugular C-fiber population. Perhaps more importantly, nodose
fibers may project to different populations of secondary neurons in the central nervous system. As much as neuropeptides
are transported to both the central and peripheral ends of the
primary afferent fiber (10), the induction of neuropeptides in
these mechanically sensitive neurons, may lead to exaggerated reflex response to innocuous stimuli. Finally, the data support the speculation that because nodose A
fibers are unresponsive to capsaicin and bradykinin (2, 17), these conventional
tools used to study the physiology of tachykinergic innervation
may not be useful to study a significant component of that
tachykinergic innervation induced by NGF.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Bradley J. Undem, Johns Hopkins Asthma and Allergy Center, 5501 Bayview Circle, Baltimore, MD 21224. E-mail: bundem{at}welchlink.welch.jhu.edu
(Received in original form August 16, 1999 and in revised form November 3, 1999).
Acknowledgments: This work was supported by NIH, Bethesda, USA.
| |
References |
|---|
|
|
|---|
1. Kummer, W., A. Fischer, R. Kurkowski, and C. Heym. 1992. The sensory and sympathetic innervation of guinea-pig lung and trachea as studied by retrograde neuronal tracing and double-labelling immunohistochemistry. Neurosci. 49: 715-737 [Medline].
2.
Riccio, M.,
W. Kummer,
A. C. Myers, and
B. J. Undem.
1996.
Interganglionic segregation of airway vagal afferent fiber phenotypes.
J. Physiol.
496:
521-530
3.
Hunter, D. D., and
B. J. Undem.
1999.
Identification and substance P
content of vagal afferent neurons innervating the epithelium of the
guinea pig trachea.
Am. J. Respir. Crit. Care Med.
159:
1-6
4.
Pedersen, K. E.,
S. N. Meeker,
M. M. Riccio, and
B. J. Undem.
1998.
Selective stimulation of jugular ganglion afferent neurons in guinea pig
airways by hypertonic saline.
J. Appl. Physiol.
84:
499-506
5. Kajekar, R., and A. C. Myers. 1999. Bradykinin stimulates guinea pig bronchial parasympathetic ganglia neurons independent of sensory nerve stimulation (abstract). Am. J. Respir. Crit. Care Med. 159: A279 .
6. Galeazza, M. T., M. G. Garry, H. J. Yost, K. A. Strait, K. M. Hargreves, and V. S. Seybold. 1995. Plasticity in the synthesis and storage of substance P and calcitonin gene-related peptide in primary afferent neurons during peripheral inflammation. Neuroscience 66: 443-458 [Medline].
7. Collins, S. M.. 1996. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 111: 1683-1699 [Medline].
8. Fujishima, H., M. Takeyama, T. Takeuchi, I. Saito, and K. Tsubota. 1997. Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis. Clin. Exp. Allergy 27: 372-378 [Medline].
9. Fischer, A., G. McGregor, A. Saria, B. Philippin, and W. Kummer. 1996. Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic inflammation. J. Clin. Invest. 98: 2284-2291 [Medline].
10. Neumann, S., T. P. Doubell, T. Leslie, and C. J. Woolf. 1996. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature 384: 360-364 [Medline].
11. Braun, A., M. Lommatzsch, G. R. Lewin, J. C. Virchow, and H. Renz. 1999. Neurotrophins: a link between airway inflammation and airway smooth muscle contractility in asthma? Int. Arch. Allergy Immunol. 118: 163-165 [Medline].
12. Sanico, A. M., V. E. Koliatsos, A. M. Stanisz, J. Bienenstock, and A. Togias. 1999. Neural hyperresponsiveness and nerve growth factor in allergic rhinitis. Int. Arch. Allergy Immunol. 118: 154-158 [Medline].
13. Lindsay, R. M., and A. J. Harmar. 1989. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 337: 362-364 [Medline].
14. Zhuo, H., H. Ichikawa, and C. J. Helke. 1997. Neurochemistry of the nodose ganglion. Prog. Neurobiol. 52: 79-107 [Medline].
15.
Lindsay, R. M.,
Y. A. Barde,
A. M. Davies, and
H. Rohrer.
1995.
Differences and similarities in the neurotrophic growth factor requirements
of sensory neurons derived from neural crest and neural placode.
J.
Cell. Sci. Suppl.
3:
115-129
16. Springall, D. R., A. Cadieux, H. Oliveira, H. Su, D. Royston, and J. M. Polak. 1987. Retrograde tracing shows that CGRP-immunoreactive nerves of rat trachea and lung originate from vagal and dorsal root ganglia. J. Auton. Nerv. Syst. 20: 155-166 [Medline].
17.
Kajekar, R.,
D. Proud,
S. N. Meeker,
A. C. Myers, and
B. J. Undem.
1999.
Characteristics of vagal afferent subtypes stimulated by bradykinin in guinea pig trachea.
J. Pharmacol. Exp. Ther.
289:
682-687
18.
Lawson, S. N., and
P. J. Waddel.
1999.
Soma neurofilament immunoreactivity is related to cell size and fibre conduction velocity in rat primary sensory neurons.
J. Physiol.
435:
41-63
19. McCarthy, P. W., and S. N. Lawson. 1989. Cell type and conduction velocity of rat primary sensory neurons with substance P-like immunoreactivity. Neuroscience 28: 745-753 [Medline].
This article has been cited by other articles:
![]() |
G. Zhang, R.-L. Lin, M. Wiggers, D. M. Snow, and L.-Y. Lee Altered expression of TRPV1 and sensitivity to capsaicin in pulmonary myelinated afferents following chronic airway inflammation in the rat J. Physiol., December 1, 2008; 586(23): 5771 - 5786. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Reynolds, R. Docherty, J. Robbins, D. Spina, and C. P. Page Adenosine induces a cholinergic tracheal reflex contraction in guinea pigs in vivo via an adenosine A1 receptor-dependent mechanism J Appl Physiol, July 1, 2008; 105(1): 187 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Morice, G. A. Fontana, M. G. Belvisi, S. S. Birring, K. F. Chung, P. V. Dicpinigaitis, J. A. Kastelik, L. P. McGarvey, J. A. Smith, M. Tatar, et al. ERS guidelines on the assessment of cough Eur. Respir. J., June 1, 2007; 29(6): 1256 - 1276. [Full Text] [PDF] |
||||
![]() |
M. S. Hazari, J. H. Pan, and A. C. Myers Nerve growth factor acutely potentiates synaptic transmission in vitro and induces dendritic growth in vivo on adult neurons in airway parasympathetic ganglia Am J Physiol Lung Cell Mol Physiol, April 1, 2007; 292(4): L992 - L1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Vaughan, M. T. Szewczyk Jr, M. J. Lanosa, C. R. DeSesa, G. Gianutsos, and J. B. Morris Adenosine Sensory Transduction Pathways Contribute to Activation of the Sensory Irritation Response to Inspired Irritant Vapors Toxicol. Sci., October 1, 2006; 93(2): 411 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Taylor-Clark and B. J. Undem Transduction mechanisms in airway sensory nerves J Appl Physiol, September 1, 2006; 101(3): 950 - 959. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-X. Wu and R. D. Dey Nerve growth factor-enhanced airway responsiveness involves substance P in ferret intrinsic airway neurons Am J Physiol Lung Cell Mol Physiol, July 1, 2006; 291(1): L111 - L118. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Undem and M. Kollarik The Role of Vagal Afferent Nerves in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 355 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Frossard, E. Naline, C. Olgart Hoglund, O. Georges, and C. Advenier Nerve growth factor is released by IL-1{beta} and induces hyperresponsiveness of the human isolated bronchus Eur. Respir. J., July 1, 2005; 26(1): 15 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Wilfong and R. D. Dey Nerve Growth Factor and Substance P Regulation in Nasal Sensory Neurons after Toluene Diisocyanate Exposure Am. J. Respir. Cell Mol. Biol., June 1, 2004; 30(6): 793 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Undem, B. Chuaychoo, M.-G. Lee, D. Weinreich, A. C. Myers, and M. Kollarik Subtypes of vagal afferent C-fibres in guinea-pig lungs J. Physiol., May 1, 2004; 556(3): 905 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Morris, P. T. Symanowicz, J. E. Olsen, R. S. Thrall, M. M. Cloutier, and A. K. Hubbard Immediate sensory nerve-mediated respiratory responses to irritants in healthy and allergic airway-diseased mice J Appl Physiol, April 1, 2003; 94(4): 1563 - 1571. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Jacoby Airway Neural Plasticity: The Nerves They Are A-Changin' Am. J. Respir. Cell Mol. Biol., February 1, 2003; 28(2): 138 - 141. [Full Text] [PDF] |
||||
![]() |
J. P. Lamb and M. P. Sparrow Three-Dimensional Mapping of Sensory Innervation with Substance P in Porcine Bronchial Mucosa: Comparison with Human Airways Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1269 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Path, A. Braun, N. Meents, S. Kerzel, D. Quarcoo, U. Raap, G. W. Hoyle, W. A. Nockher, and H. Renz Augmentation of Allergic Early-Phase Reaction by Nerve Growth Factor Am. J. Respir. Crit. Care Med., September 15, 2002; 166(6): 818 - 826. [Abstract] [Full Text] |
||||
![]() |
K. A. Moore, E. J. Oh, and D. Weinreich 5-HT3 receptors mediate inflammation-induced unmasking of functional tachykinin responses in vitro J Appl Physiol, June 1, 2002; 92(6): 2529 - 2534. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Carr, D. D. Hunter, D. B. Jacoby, and B. J. Undem Expression of Tachykinins in Nonnociceptive Vagal Afferent Neurons during Respiratory Viral Infection in Guinea Pigs Am. J. Respir. Crit. Care Med., April 15, 2002; 165(8): 1071 - 1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Myers, R. Kajekar, and B. J. Undem Allergic inflammation-induced neuropeptide production in rapidly adapting afferent nerves in guinea pig airways Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L775 - L781. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. TOBIN Asthma, Airway Biology, and Allergic Rhinitis in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1559 - 1580. [Full Text] [PDF] |
||||
![]() |
K. Kwong, Z.-X. Wu, M. L. Kashon, K. M. Krajnak, P. M. Wise, and L.-Y. Lee Chronic Smoking Enhances Tachykinin Synthesis and Airway Responsiveness in Guinea Pigs Am. J. Respir. Cell Mol. Biol., September 1, 2001; 25(3): 299 - 305. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |